Literature DB >> 12917625

Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines.

Martha R Stampfer1, James Garbe, Tarlochan Nijjar, Don Wigington, Karen Swisshelm, Paul Yaswen.   

Abstract

We describe novel effects of p53 loss on immortal transformation, based upon comparison of immortally transformed human mammary epithelial cell (HMEC) lines lacking functional p53 with closely related p53(+) lines. Our previous studies of p53(+) immortal HMEC lines indicated that overcoming the stringent replicative senescence step associated with critically short telomeres (agonescence), produced indefinite lifespan lines that maintained growth without immediately expressing telomerase activity. These telomerase(-) 'conditionally immortal' HMEC underwent an additional step, termed conversion, to become fully immortal telomerase(+) lines with uniform good growth. The very gradual conversion process was associated with slow heterogeneous growth and high expression of the cyclin-dependent kinase inhibitor p57(Kip2). We now show that p53 suppresses telomerase activity and is necessary for the p57 expression in early passage p53(+) conditionally immortal HMEC lines, and that p53(-/-) lines exhibit telomerase reactivation and attain full immortality much more rapidly. A p53-inhibiting genetic suppressor element introduced into early passages of a conditionally immortal telomerase(-) p53(+) HMEC line led to rapid induction of hTERT mRNA, expression of telomerase activity, loss of p57 expression, and quick attainment of uniform good growth. These studies indicate that derangements in p53 function may impact malignant progression through direct effects on the conversion process, a potentially rate-limiting step in HMEC acquisition of uniform unlimited growth potential. These studies also provide evidence that the function of p53 in suppression of telomerase activity is separable from its cell cycle checkpoint function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917625     DOI: 10.1038/sj.onc.1206667

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients.

Authors:  Guillaume Voghel; Nathalie Thorin-Trescases; Nada Farhat; Aida M Mamarbachi; Louis Villeneuve; Annik Fortier; Louis P Perrault; Michel Carrier; Eric Thorin
Journal:  Mech Ageing Dev       Date:  2008-01-20       Impact factor: 5.432

2.  Facilitates chromatin transcription complex is an "accelerator" of tumor transformation and potential marker and target of aggressive cancers.

Authors:  Henry Garcia; Jeffrey C Miecznikowski; Alfiya Safina; Mairead Commane; Anja Ruusulehto; Sami Kilpinen; Robert W Leach; Kristopher Attwood; Yan Li; Seamus Degan; Angela R Omilian; Olga Guryanova; Olympia Papantonopoulou; Jianmin Wang; Michael Buck; Song Liu; Carl Morrison; Katerina V Gurova
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

3.  TRIM24 links glucose metabolism with transformation of human mammary epithelial cells.

Authors:  T N Pathiraja; K N Thakkar; S Jiang; S Stratton; Z Liu; M Gagea; X Shi; P K Shah; L Phan; M-H Lee; J Andersen; M Stampfer; M C Barton
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

4.  Differences in telomerase activity between colon and rectal cancer.

Authors:  Georgios D Ayiomamitis; George Notas; Apostolos Zaravinos; Adamantia Zizi-Sermpetzoglou; Maria Georgiadou; Ourania Sfakianaki; Elias Kouroumallis
Journal:  Can J Surg       Date:  2014-06       Impact factor: 2.089

5.  Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells.

Authors:  Paul L Severson; Lukas Vrba; Martha R Stampfer; Bernard W Futscher
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2014-11-04       Impact factor: 2.873

6.  Short Telomeres Induce p53 and Autophagy and Modulate Age-Associated Changes in Cardiac Progenitor Cell Fate.

Authors:  Collin Matsumoto; Yan Jiang; Jacqueline Emathinger; Pearl Quijada; Nathalie Nguyen; Andrea De La Torre; Maryam Moshref; Jonathan Nguyen; Aimee B Levinson; Minyoung Shin; Mark A Sussman; Nirmala Hariharan
Journal:  Stem Cells       Date:  2018-02-25       Impact factor: 6.277

7.  Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells.

Authors:  James C Garbe; Sanchita Bhattacharya; Batul Merchant; Ekaterina Bassett; Karen Swisshelm; Heidi S Feiler; Andrew J Wyrobek; Martha R Stampfer
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

8.  Immortalization of epithelial progenitor cells mediated by resveratrol.

Authors:  V P Pearce; J Sherrell; Z Lou; L Kopelovich; W E Wright; J W Shay
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

9.  Expression profile and prognostic importance in prostate lesions of the reverse transcriptase component of human telomerase (hTERT) and of cyclin-dependent kinase inhibitor p57 (p57kip2a).

Authors:  Pinar Atasoy; Erdal Yilmaz; Onder Bozdogan; Sebnem Ayva; Ertan Batislam
Journal:  Int Urol Nephrol       Date:  2008-06-03       Impact factor: 2.370

10.  p53-dependent integration of telomere and growth factor deprivation signals.

Authors:  Alain Beliveau; Ekaterina Bassett; Alvin T Lo; James Garbe; Miguel A Rubio; Mina J Bissell; Judith Campisi; Paul Yaswen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.